3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
10
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Pain, Postoperative
3
Neurotoxicity Syndromes
3
Melanoma
3
Leukemia, Myeloid, Acute
3
Brain Neoplasms
3
Recurrence
2
Ovarian Neoplasms
2
Hemorrhage
2
Chronic Pain
2
Agnosia
2
Vulvodynia
1
Uterine Cervical Neoplasms
1
Stomatitis
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Seizures
1
Radiodermatitis
1
Radiation Injuries
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Parathyroid Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Interventions
Paclitaxel
45
Carboplatin
33
Bevacizumab
17
liposomal doxorubicin
15
Topotecan
12
Taxes
10
Gemcitabine
10
Drug Therapy
6
Cisplatin
6
rucaparib
5
mirvetuximab soravtansine
5
Docetaxel
5
Immunoglobulin G
4
Doxorubicin
4
Disulfides
4
trebananib
3
pembrolizumab
3
olaparib
3
Saline Solution
3
Neoadjuvant Therapy
3
Hyperthermic Intraperitoneal Chemotherapy
3
Dexamethasone
3
CP protocol
3
niraparib
2
cediranib
2
Tamoxifen
2
Specimen Handling
2
Letrozole
2
Glucose
2
Cytoreduction Surgical Procedures
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Fallopian Tube Neoplasms
×
Sodium Chloride
×
Clear all
NCT04201561
2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3
Unknown
68 enrolled